相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats
Aaro J. Jalkanen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics
Kotaro Omori et al.
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats
Yasuo Uchida et al.
MOLECULAR PHARMACEUTICS (2020)
L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)
Johanna Huttunen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug
Nikki A. Thiele et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Structural properties for selective and efficient L-type amino acid transporter 1 (LAT1) mediated cellular uptake
Jussi Karkkainen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Role of Blood-Brain Barrier in Alzheimer's Disease
Zhiyou Cai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions
Wan Sun et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs
Mikko Gynther et al.
MOLECULAR PHARMACEUTICS (2016)
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure
Mikko Gynther et al.
NEUROCHEMICAL RESEARCH (2016)
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Improving Drug Delivery to Primary and Metastatic Brain Tumors: Strategies to Overcome the Blood-Brain Barrier
K. E. Parrish et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib
Mark C. de Gooijer et al.
INVESTIGATIONAL NEW DRUGS (2015)
Blood-brain barrier modeling: challenges and perspectives
Tobias Ruck et al.
NEURAL REGENERATION RESEARCH (2015)
Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport
Muhammad Waqas Sadiq et al.
PLOS ONE (2015)
Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
Marion Peyressatre et al.
CANCERS (2015)
Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain
Laura Kervezee et al.
AAPS JOURNAL (2014)
Quantitative Insight into the Design of Compounds Recognized by the L-Type Amino Acid Transporter 1 (LAT1)
Henna Ylikangas et al.
CHEMMEDCHEM (2014)
Quantitative Atlas of Blood-Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
Yutaro Hoshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice
Yasuo Uchida et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Overview of P-glycoprotein inhibitors: a rational outlook
Kale Mohana Raghava Srivalli et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Large Amino Acid Transporter 1 (LAT1) Prodrugs of Valproic Acid: New Prodrug Design Ideas for Central Nervous System Delivery
Lauri Peura et al.
MOLECULAR PHARMACEUTICS (2011)
Brain uptake of ketoprofen-lysine prodrug in rats
Mikko Gynther et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine Administration
Rong Zhao et al.
DRUG METABOLISM AND DISPOSITION (2009)
Assessment of Blood-Brain Barrier Permeability Using the In Situ Mouse Brain Perfusion Technique
Rong Zhao et al.
PHARMACEUTICAL RESEARCH (2009)
Large neutral amino acid transporter enables brain drug delivery via prodrugs
Mikko Gynther et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique
H Murakami et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
分享论文
